[1]
|
Bousson V, Moretti JL, Weinmann P, et al. Assessment of malignancy in pulmonary lesions:FDG dual-head coincidence gamma camera imaging in association with serum tumor marker measurement[J]. J Nucl Med, 2000, 41:1801-1807. |
[2]
|
Ak I, Blokland JAK, Pauwels EKJ, et al. The clinical value of 18FDG detection with a dual-head coincidence camera:a review[J]. Eur J Nucl Med, 2001, 28:763-772. |
[3]
|
Delbeke D, Sandler MPl. The role of hybrid cameras in oncology[J]. Semin Nucl Med, 2000, 30:268-280. |
[4]
|
Patton JA, Turkington TG. Coincidence imaging with a dual-head scintillation camera[J]. J Nucl Med, 1999, 40:432-441. |
[5]
|
Ruhlmann J, Oehr P, Biersack HJ, et al. PET in oncology[M]. Berlin:spriger, 1999. 10-14. |
[6]
|
Lowe VJ, fletcher JW, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules[J]. J Clin Oncol, 1998, 16:1075-1084. |
[7]
|
Bar-Shalom R, Valdivia AY, Blaufox MD, et al. PET imaging in oncology[J]. Semin Nucl Med, 2000, 30:150-185. |
[8]
|
Bury T, Dowlati A, Paulus P, et al. Whole-body 18F-FDG positron emission tomography in the staging of non-small cell lung cancer[J]. Eur Respir J, 1997, 10:2529-2534. |
[9]
|
Drane WE, Abbott FD, Nicole MW, et al. Technology for FDG-SPECT with a relatively inexpensive gamma-camera[J]. Radiology, 1994, 191:461-465. |
[10]
|
Martin WH, Delbeke D, Patton JA, et al. Detection of malignancies with SPECT versus PET, with 18F-fluorodeoxyglucose[J]. Radiology, 1996, 198:225-231. |
[11]
|
Shreve PD, Steventon PS, Deters EC, et al. Ocologic diagnosis with 18F-fluorodeoxyglucose imaging:dual-head coincidence gamma camera versus positron emission tomogaphic scanner[J]. Radiology, 1998, 207:431-437. |
[12]
|
Tatsumi M, Yutani K, Watanabe Y, et al. Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer:comparison with FDG PET[J]. J Nucl Med, 1999, 40:566-573. |
[13]
|
Delbeke D, Patton JA, Martin WH, et al. FDG PET and dual-head gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders[J]. J Nucl Med, 1999, 40:110-117. |
[14]
|
Weber W, Young C,. Abdel-Dayem HM, et al. Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma camera[J]. J Nucl Med, 1999, 40:574-578. |
[15]
|
Higashi K, Ueda Y, Seki H, et al. Fluorine-18-FDG imaging is negative in bronchioloalveolar carcinoma[J]. J Nucl Med, 1998, 39:1016-1020. |
[16]
|
Kapucu LO, Meltzer CC, Townsend DW, et al. Fluorine-18-fluorodeoxyglucose uptake in pneumonia[J]. J Nucl Med, 1998, 39:1267-1269. |
[17]
|
Israel O, Keidar Z, Iosilevsky G, et al. The fusion of anatomic and physiologic imaging in the management of patients with cancer[J]. Semin Nucl Med, 2001, 31:191-205. |